These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35273095)

  • 1. Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.
    Sgouros G; Dewaraja YK; Escorcia F; Graves SA; Hope TA; Iravani A; Pandit-Taskar N; Saboury B; James SS; Zanzonico PB
    J Nucl Med; 2022 May; 63(5):804. PubMed ID: 35273095
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.
    Kao YH
    J Nucl Med; 2022 May; 63(5):803. PubMed ID: 34933892
    [No Abstract]   [Full Text] [Related]  

  • 3. Internal dosimetry in the use of radiopharmaceuticals in therapy--science at a crossroads?
    Stabin MG
    Cancer Biother Radiopharm; 1999 Apr; 14(2):81-9. PubMed ID: 10850291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific Developments in Imaging and Dosimetry for Molecular Radiotherapy.
    Bardiès M; Gear JI
    Clin Oncol (R Coll Radiol); 2021 Feb; 33(2):117-124. PubMed ID: 33281018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies.
    Hou X; Brosch J; Uribe C; Desy A; Böning G; Beauregard JM; Celler A; Rahmim A
    J Nucl Med; 2021 Jul; 62(7):1006-1011. PubMed ID: 33127625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of [177Lu]PSMA-617 tumor uptake based on voxel-wise 3D Monte Carlo tumor dosimetry in patients with metastasized castration resistant prostate cancer.
    Götz TI; Lang EW; Prante O; Cordes M; Kuwert T; Ritt P; Ludwig B; Schmidkonz C
    Nuklearmedizin; 2020 Sep; 59(5):365-374. PubMed ID: 32663888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of dosimetry for Systemic Targeted Radionuclide Therapy (STaRT).
    Wessels BW; Syh JH; Meredith RF
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S39-45. PubMed ID: 16979438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: the case for patient-specific dosimetry in radionuclide therapy.
    Stabin MG
    Cancer Biother Radiopharm; 2008 Jun; 23(3):273-84. PubMed ID: 18593360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
    Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric model for locoregional treatments of brain tumors with 90Y-conjugates: clinical application with 90Y-DOTATOC.
    Ferrari M; Cremonesi M; Bartolomei M; Bodei L; Chinol M; Fiorenza M; Tosi G; Paganelli G
    J Nucl Med; 2006 Jan; 47(1):105-12. PubMed ID: 16391194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC.
    Schuchardt C; Kulkarni HR; Prasad V; Zachert C; Müller D; Baum RP
    Recent Results Cancer Res; 2013; 194():519-36. PubMed ID: 22918780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody.
    Emfietzoglou D; Kostarelos K; Papakostas A; Yang WH; Ballangrud A; Song H; Sgouros G
    J Nucl Med; 2005 Jan; 46(1):89-97. PubMed ID: 15632038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ON THE DOSIMETRY OF NEGATIVE PIONS WITH A VIEW TOWARD THEIR TRIAL IN CANCER THERAPY. UCRL-11387.
    RICHMAN C; ACETO H; RAJU MR; SCHWARTZ B; WEISSBLUTH M
    UCRL US At Energy Comm; 1964; 31():114-26. PubMed ID: 24547286
    [No Abstract]   [Full Text] [Related]  

  • 15. [131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
    Kumar P; McQuarrie SA; Zhou A; McEwan AJ; Wiebe LI
    Nucl Med Biol; 2005 Aug; 32(6):647-53. PubMed ID: 16026712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Case for Dosimetry in Alpha-Emitter Therapy.
    Sgouros G
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S45-S46. PubMed ID: 31537496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Pharmacokinetics and Dosimetry Studies of
    Marsh IR; Grudzinski J; Baiu DC; Besemer A; Hernandez R; Jeffery JJ; Weichert JP; Otto M; Bednarz BP
    J Nucl Med; 2019 Oct; 60(10):1414-1420. PubMed ID: 30926646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment planning in molecular radiotherapy.
    Glatting G; Bardiès M; Lassmann M
    Z Med Phys; 2013 Dec; 23(4):262-9. PubMed ID: 23597414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the art of in vivo dosimetry.
    Mijnheer B
    Radiat Prot Dosimetry; 2008; 131(1):117-22. PubMed ID: 18765403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE ZURICH PROPOSAL FOR RADIOMETRY AND DOSIMETRY].
    SCHINZ HR; WIDEROEE R
    Strahlentherapie; 1965 May; 127():1-13. PubMed ID: 14310661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.